Liver cell-targeted delivery of therapeutic molecules

Jeong Hun Kang, Riki Toita, Masaharu Murata

研究成果: Contribution to journalReview article

23 引用 (Scopus)

抜粋

The liver is the largest internal organ in mammals and is involved in metabolism, detoxification, synthesis of proteins and lipids, secretion of cytokines and growth factors and immune/inflammatory responses. Hepatitis, alcoholic or non-alcoholic liver disease, hepatocellular carcinoma, hepatic veno-occlusive disease, and liver fibrosis and cirrhosis are the most common liver diseases. Safe and efficient delivery of therapeutic molecules (drugs, genes or proteins) into the liver is very important to increase the clinical efficacy of these molecules and to reduce their side effects in other organs. Several liver cell-targeted delivery systems have been developed and tested in vivo or ex vivo/in vitro. In this review, we discuss the literature concerning liver cell-targeted delivery systems, with a particular emphasis on the results of in vivo studies.

元の言語英語
ページ(範囲)132-143
ページ数12
ジャーナルCritical Reviews in Biotechnology
36
発行部数1
DOI
出版物ステータス出版済み - 1 2 2016

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Applied Microbiology and Biotechnology

フィンガープリント Liver cell-targeted delivery of therapeutic molecules' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用